论文部分内容阅读
心肌梗塞(MI)后室性早搏(VE)是突发和非突发的心原性死亡的一个危险因子。抑制 VE 可能会降低 MI 后的猝死率。本试验是一项多中心,随机化,以安慰剂组为对照用英卡胺、氟卡胺、Moncizine 对无症状或轻微症状的室性心律失常的抑制能否减少 MI 后猝死率的研究。后因英卡胺、氟卡胺组死亡率过高而中止。本文报告对病人接受英卡胺、
Post-myocardial infarction (MI) premature ventricular contractions (VE) are a risk factor for both sudden and non-sudden cardiogenic death. Inhibition of VE may reduce the rate of sudden death after MI. This trial is a multicenter, randomized, placebo-controlled study of whether instillation of either acetylcarnamine, flecainide, or Moncizine for asymptomatic or mild symptoms of ventricular arrhythmias can reduce the rate of sudden death after MI. After the celecoxib, flecainide group mortality was too high and suspended. This article reports on patients receiving enka amine,